NUTRIVENTION-3: The Gut-Bone Marrow Connection

The Trial That Changes Everything

Memorial Sloan Kettering Cancer Center's NUTRIVENTION-3 trial (NCT05640843) represents something rare in medicine: a well-designed, placebo-controlled study testing whether dietary intervention can alter disease trajectory. Not symptom management—actual disease biology.

Led by Dr. Urvi Shah, this trial randomizes 150 patients with MGUS (Monoclonal Gammopathy of Undetermined Significance) and SMM (Smoldering Multiple Myeloma) to plant-based dietary intervention versus placebo. The primary endpoint is change in stool butyrate levels at 12 weeks.

Why butyrate? Because the researchers understand what the VSI framework has been documenting: butyrate produced by gut bacteria inhibits the NF-κB pathway that drives plasma cell proliferation. Diet → fiber → fermentation → butyrate → pathway modulation → disease biology. It's a causal chain, and NUTRIVENTION-3 is testing it rigorously.

Published Results So Far

Results from the pilot NUTRIVENTION trial were presented at the American Society of Hematology Annual Meeting in December 2024. They validate the mechanistic framework.

Metabolic improvements: 7% sustained BMI reduction lasting up to one year, improved fasting insulin levels, increased adiponectin-to-leptin ratio indicating enhanced insulin sensitivity.

Microbiome changes: Improved gut microbiome diversity, increased abundance of butyrate-producing bacteria, sustained effects even one year post-intervention.

Inflammatory markers: Reduced C-reactive protein, reduced neutrophil count, increased CD14 classical monocytes (anti-inflammatory), reduced CD16 non-classical monocytes (pro-inflammatory).

Disease trajectory: Two patients showed reduction in long-term progression trajectory—the first interventional evidence that diet can alter MGUS/SMM disease course.

Mouse model validation using the Vk*MYC model showed even more striking results: 40% of mice on high-fiber diet did NOT progress to active multiple myeloma versus 100% progression in controls. Median progression-free survival increased 2.5-fold (30 weeks versus 12 weeks).

What VSI Adds

NUTRIVENTION-3 demonstrates that dietary intervention works. VSI explains why it works at the ecological level—and what to do when it doesn't.

The trial measures stool butyrate, but stool butyrate is the residual after colonocytes absorb what they need. It doesn't reveal whether the cross-feeding guild is intact. A patient could show increased stool butyrate while having a fragile ecosystem that will collapse under stress.

VSI's contribution is the guild framework. Butyrate production requires an assembly line of bacterial specialists: primary degraders to break down fiber, acetate producers to provide the co-substrate for butyrate synthesis, hydrogen consumers to maintain favorable thermodynamics, and colonocytes burning butyrate to maintain the oxygen-free environment the anaerobes need. If any station fails, the whole line stops.

This explains response variability. Some patients will respond robustly to fiber intervention because their guild is intact. Others will see no benefit—or even worsening symptoms—because the machinery is broken. For those patients, VSI offers the dual-pathway approach: exogenous butyrate support while rebuilding endogenous production capacity.

The Functional Omnivory Enhancement

NUTRIVENTION-3 uses a vegan protocol for research clarity—isolating the fiber-butyrate variable for controlled study. This is appropriate for demonstrating causation. But for long-term clinical implementation, VSI advocates functional omnivory: the evidence-based dietary pattern that Blue Zone populations actually followed.

Functional omnivory provides diverse fermentable fibers from vegetables, legumes, and whole grains (supporting the guild). It provides collagen and glycine from bone broth and connective tissue (supporting gut barrier integrity). It provides EPA and DHA from fatty fish (directly anti-inflammatory and supporting microbiome diversity). It provides vitamin K2 from fermented dairy (essential for calcium metabolism). It provides fermented dairy from kefir and traditional yogurt (stimulating butyrate production and enhancing SCFA-producing bacteria).

A vegan protocol eliminates variables. Functional omnivory delivers complete ecosystem support.

The Dual NF-κB Strategy

NUTRIVENTION targets NF-κB through the butyrate-HDAC pathway. VSI's framework adds a second vector: dietary polyphenols, particularly cyanidin-3-glucoside (C3G) found in berries and purple vegetables, that inhibit NF-κB through IκB-α phosphorylation blockade while simultaneously activating the cytoprotective Nrf2 pathway.

Both pathways require an intact colonic ecosystem. The cross-feeding guild produces butyrate; bacterial enzymes convert anthocyanins to active metabolites. A degraded microbiome can't execute either arm of the strategy.

This represents convergent attack on the inflammatory master switch through complementary mechanisms. Traditional diets delivered both fiber and polyphenols; modern interventions should do the same.

Practical Kitchen Tools

Reconstructing a functional microbiome doesn't require specialty products or dramatic behavior change. Traditional cuisines discovered practical methods that modern science is only now explaining.

The cook-cool-reheat transformation converts digestible starch into resistant starch (RS3). Potatoes boiled, refrigerated overnight, and reheated the next day have 3-4% RS by weight. Day-old rice fried with vegetables. Pasta salad from yesterday's spaghetti. Every traditional cuisine has versions of this.

The freezer as health food factory: freezing sourdough bread and toasting from frozen creates RS3 while preserving the organic acids from fermentation. Frozen bananas in smoothies convert sugar to prebiotic substrate.

These zero-marginal-cost interventions—timing shifts, temperature manipulation, batch cooking—represent optimization within existing patterns. No subscriptions required.